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Abstract: Acinetobacter pittii is a species that belong to the Acinetobacter calcoaceticus-baumannii com-
plex, increasingly recognized as major nosocomial bacterial pathogens, often associated with multiple
drug-resistances. The capsule surrounding the bacteria represents a main virulence factor, helping
cells avoid phage predation and host immunity. Accordingly, a better understanding of the phage
infection mechanisms is required to efficiently develop phage therapy against Acinetobacter of dif-
ferent capsular types. Here, we report the isolation of the novel A. pittii-infecting Fri1-like phage
vB_Api_3043-K38 (3043-K38) of the Podoviridae morphotype, from sewage samples. Its 41,580 bp
linear double-stranded DNA genome harbours 53 open reading frames and 302 bp of terminal
repeats. We show that all studied Acinetobacter Fri1-like viruses have highly similar genomes, which
differentiate only at the genes coding for tailspike, likely to adapt to different host receptors. The
isolated phage 3043-K38 specifically recognizes an untapped Acinetobacter K38 capsule type via a
novel tailspike with K38 depolymerase activity. The recombinant K38 depolymerase region of the
tailspike (center-end region) forms a thermostable trimer, and quickly degrades capsules. When the
K38 depolymerase is applied to the cells, it makes them resistant to phage predation. Interestingly,
while K38 depolymerase treatments do not synergize with antibiotics, it makes bacterial cells highly
susceptible to the host serum complement. In summary, we characterized a novel phage-encoded
K38 depolymerase, which not only advances our understanding of phage-host interactions, but could
also be further explored as a new antibacterial agent against drug-resistant Acinetobacter.
Keywords: Acinetobacter baumannii; bacteriophage; tailspike; depolymerase; anti-virulence; capsule
1. Introduction
Acinetobacter calcoaceticus-baumannii complex (ACB complex) is a leading oppor-
tunistic nosocomial pathogen. This complex consists of five closely related species:
Acinetobacter baumannii, Acinetobacter nosocomialis, Acinetobacter pittii, Acinetobacter seifertii
and Acinetobacter dijkshoorniae, and also one non-pathogenic species: Acinetobacter calcoaceticus.
Treatment of ACB complex species associated infections is extremely difficult due to
their multi-resistance to several classes of antibiotics [1]. The alarming emergency of
carbapenem-resistant clones, together with the lack of viable antimicrobial options, has
placed A. baumannii as the leading priority pathogen since 2017 by the World Health Orga-
nization. However, this should be carefully interpreted, as hospital routines cannot easily
distinguish among species of the ACB complex, often identifying A. baumannii by default.
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Accordingly, recent studies have reported that A. pittii is sometimes more prevalent than
A. baumannii in blood cultures [2].
A thick capsular polysaccharide coat typically displayed in ACB complex strains
is considered a major virulence factor [3]. Different genes responsible for the synthesis,
assembly and exportation of capsule polysaccharides (K types) have evolved to produce
variable serotypes, as a consequence of constant interactions of the bacterium with the host
immunity, other eukaryotic cells and bacteriophage (phages) [4]. Currently, ACB complex
is known to display more than 125 different K types [5]. This variety might also be related
to different degrees of clinical manifestation of infections and antibiotic resistances.
ACB complex phages (i.e., viruses infecting specifically ACB bacteria) have been
investigated as a possible alternative medicine to antibiotics, in the frame of the so-called
phage therapy. In 2017, a total of 42 Acinetobacter phage genome sequences were avail-
able in public databases. Comparative analysis of their genomes and proteomes revealed
that Acinetobacter phage population was composed of six groups. Phages of the subfam-
ily Autographivirinae and Fri1virus genus at the time were represented by nine phages of
Podoviridae morphotype (AB3, Abp1, IME-200, phiAB1, phiAB6, PD-AB9, PD-6A3, WCH-
ABP5). All have evolved to encode tailspikes with capsular depolymerase activities that
specifically recognize bacterial K types, allowing phages to infect the bacterium. Since then,
Acinetobacter phage genome numbers have increased by three-fold. Although Acinetobacter
phages with capsular depolymerases have been found in different taxonomic groups, they
were predominantly identified in Fri1virus-like phages. Currently, 17 distinct ACB complex
K-specific depolymerases have been identified in phage proteomes (K1–2, K9, K19, K27,
K30, K32, K37, K44–45, K47–48, K87, K89, K91, K93 and K116) [6–10].
In the continuous search to disclose the full diversity of phage-host capsular inter-
actions, we isolated a novel phage against an untapped A. pittii K38 capsule type. The
Fri1-like phage vB_Api_3043-K38 (3043-K38) encodes a novel tailspike protein responsible
for its specific interaction with A. pittii K38. We report here the isolation and full characteri-
zation of this new tailspike protein carrying a K38-depolymerase activity, thus advancing
our current knowledge about the mechanisms of phage interaction with bacterial strains of
the ACB complex.
2. Results
2.1. A. pittii Ap45 Has a OXA β-Lactamase and a K38 Capsular Type
Ap45 strain was isolated from a wound of a patient at the University Hospital of
Lausanne (CHUV), Switzerland. Sequencing yielded 3,491,380 million 150-bp paired-end
reads, representing an average coverage of 65.6x. De novo assembly of the Ap45 genome
yielded 39 contigs (>500 bp) with a total size of 4,058,915 Kb, and a GC-content of 38.7%.
The assembly N50 value was 295,941 kb. Average nucleotide identity (ANI) against type
strains of A. pittii (APQP00000000) and A. baumannii (CP046654) were 97.44% and 87.53%,
respectively. ANI values ≥ 96% strongly indicated identity at the species level [11], i.e.,
the genome was clearly derived from an A. pittii strain. The genome encoded 3,918 genes,
62 tRNA genes, 4 ncRNA, 3 rRNA genes, and 1 tmRNA. Assembled contigs were also
predicted to encode an OXA-213-like β-lactamase OXA-500 oxacillinase gene (blaOXA-500).
Additionally, a capsular synthesis locus of the K38 type was identified with good confidence
(i.e., 91% coverage and 98% identity).
2.2. Phage 3043-K38 Is a New Fri1-like Virus Infecting the A. pittii K38 Capsule Type
We isolated a new phage named vB_Api_3043-K38 (referred to as 3043-K38) infecting
only K38 strains out of 29 different Acinetobacter K types tested. After overnight incubation,
phage produced clear plaques (~2 mm in diameter) surrounded with halos (~7 mm in
diameter) (Figure 1A). While phage plaques maintained their size, the halos increased over
time. Based on transmission electron microscopy (TEM) analysis, 3043-K38 harboured an
icosahedral symmetric capsid (56 nm vertex to vertex) and a short noncontractile tail (9 nm
head edge to tail end), featuring a Podoviridae morphotype (Figure 1B).
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2.3. Tailspike Carries a Novel K38 Depolymerase Activity 
Like other described phage tailspikes [13], the 742-aa-long tailspike of phage 3043-
K38 is predicted to have a N-terminal anchor domain and a centre depolymerase domain 
(Figure 2A). A putative C-terminal chaperone described in some homologs was not de-
tected. At the primary sequence level, only the N-terminal domain (1–121 aa) was similar 
to other Acinetobacter phage tailspikes (>70% aa identity). At the structural level, the N-
terminal and centre regions (1–451 aa) were similar to the Acinetobacter phage phiAB6 tail-
spike (E-value of 1.6E−10). PFAM also predicted a pectate lyase 3 domain in the middle 
region (201–225 aa, protein family PF12708.6) although with low identity (E-value of 2.1). 
This region has been associated with beta-helix enzymes with capsular depolymerase ac-
tivities [6]. 
We decided to heterologously express the tailspike middle and C-terminal region 
(147–742 aa) in E. coli, predicted to encode the capsular depolymerase domain and its pu-
tative chaperone, respectively (Figure 2B). Drop tests showed halos only against the K38 
strain, mimicking the haziness of the phage 3043-K38 plaques (Figure 2C). The K38 
Figure 1. Morphological and genomic analysis of phage 3043-K38. (A) morphological i ages of the phage plaque and
(B) TEM micrographs (scale bar, 100 nm) negatively stained with 2% uranyl acetate. (C) Genomic ap of phage 3043-K38
(53 predicted proteins are coloured according to their function) compared with Acinetobacter phage APK128 using the
Easyfig [12] program and TBLASTX comparisons.
The phage 3043-K38 had a 41,882-bp double-stranded DNA with 302-bp direct termi-
nal repeats (DTRs), and a GC content of 39.3%. 53 genes were predicted to encode proteins
with function related to DNA repl cation, repair and modification, cell lysis and DNA
packaging as well as structural proteins (Figure 1C). Ph ge 3043-K38 shared substantial
nucleotide identity (80%) and (>85%) genes with many Acinetobacter Fri1-like viruses,
such as vB_AbaP_APK128 (MW459163), vB_AbaP_APK116 (MN807295), and vB_ApiP_P2
(NC_042007). The high genomic and proteomic similarity between our phage 3043-K38 and
the above-mentioned viruses that belong to the Autographiviridae family and Friunavirus
genus, support the Podoviridae morphotype of the phage 3043-K38. Whole genome com-
parison showed that Acinetobacter Fri1-like viruses have highly similar genomes, and
that a main difference can be found at the gene encoding for the tailspike depolymerase
(Figure 1C).
2.3. Tailspike Carries a Novel K38 Depolymerase Activity
Like other described phage tailspikes [13], the 742-aa-long tailspike of phage 3043-K38
is predicted to have a N-terminal anchor domain and a centre depolymerase domain
(Figure 2A). A putative C-terminal chaperone described in some homologs was not detected.
At the primary sequence level, only the N-terminal domain (1–121 aa) was similar to other
Acinetobacter phage tailspikes (>70% aa identity). At the structural level, the N-terminal
and centre regions (1–451 aa) were similar to the Acinetobacter phage phiAB6 tailspike
(E-value of 1.6 × 10−10). PFAM also predicted a pectate lyase 3 domain in the middle
region (201–225 aa, protein family PF12708.6) although with low identity (E-value of 2.1).
This region has been associated with beta-helix enzymes with capsular depolymerase
activities [6].
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merase region identified. (B) 12% SDS-PAGE separation gel (GRS Protein Marker) of the purified protein. (C) Spot test of the
capsular depolymerase on agar plates against K38 cells. (D) size exclusion chromatography of samples loaded to a Superose
6 10/300 GL column ( Au, micro absorbance unit). Capsular depolymerase was eluted as a single peak corresponding to a
molecular weight of 146.25 kDa, based on the calibrati n curve of log MW vs. Ve/V0 (Ve, e ution volume; V0, void volume)
generated with calibration standards (Merk). (E) Circular dichroism analysis of the purified protein (1 mg; mea ured in the
far-UV) and (F) its thermal unfol ing acquired at 217 nm. Circular dichroism spectroscopy was performed with proteins
dialyzed in potassium phosphate buffer (pH 7.0).
We decided to heterologously express the tailspike middle and C-terminal region
(147–742 aa) in E. coli, predicted to encode the capsular depolymerase domain and its
putative chaperone, respectively (Figure 2B). Drop tests showed halos only against the
K38 strain, mimicking the haziness of the phage 3043-K38 plaques (Figure 2C). The K38
depolymerase was active in the 0.0001 µM range. Moreover, it was able to degrade extracted
exopolysaccharides, from 20 ◦C to 90 ◦C (Supplemental Figure S1).
2.4. K38 Depolymerase Is a Heat-Resistant Trimeric Protein
The his-tagged, expressed K38 depolymerase corresponds to a 630-aa protein and a
heterologously theoretical mass of 67 kDa, which is contrasted with its molecular mass of
55 kDa, obtained after electrophoresis in polyacrylamide gel under denaturing conditions
(Figure 2B). In addition, analytical size-exclusion chromatography showed a single homo-
geneo s peak at around 146 kDa (peak at 13.28 mL), close to he trimeric value calculated
from the electrophoresis (i.e., 165 kDa). This indicated that the protein likely forms trimers
in solution (Figure 2D).
Circular dichroism (CD) was performed to evaluate the K38 depolymerase secondary
structure content. CD spectrum demonstrated that the K38 depolymerase is a β-sheet-
rich protein, as it displayed a single characteristic minimum peak at 217 nm (Figure 2E).
With a complementary analysis of a second PSIPRED progr m, we confi med that K38
depolymerase has a higher content of β-structures (43%), followed by α-helices (18%), being
the remaining regions coiled. The CD was also used to analyse the structure thermostability
of the K38 depolymerase. Thermal denaturation produced a sigmoidal curve, reflecting
protein unfolding (Figure 2F). The melting temperature (Tm) i.e., midpoint, was measured
at 85.6 ◦C.
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2.5. Recombinant K38 Depolymerase Quickly Removes Capsules, Making Bacterial Cells Immune
to Phage
To deepen our understanding of the capsular depolymerase role during phage infec-
tion, we performed two independent experiments. In the adsorption assay (Figure 3A),
phage 3043-K38 adsorbed with high efficiency (96.3% adsorption) on its host K38 but
adsorption was significantly affected on depolymerase-treated cells (6.3% adsorption)
(p < 0.001). In contrast, the adsorption of 3043-K38 was observed on neither non-treated
nor on depolymerase-treated K1 cells (i.e., not susceptible to 3043-K38 or the recombinant
depolymerase, 2.9% and 3.6% adsorption, respectively). Binding assays showed that the
interaction between the recombinant K38 depolymerase and the capsule is transient and
fast, the enzyme being released already by 10 s (Figure 3B).
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Figure 3. Tailspike interaction with capsules. (A) Adsorption rate of phage 3043-K38 particles in K38 host cells pre-treated
with PBS (control) or K38 depolymerase at 1 µM (test), obtained by subtracting the titre before (total phage titre) and after
centrifugation (non-adsorbed phage titre). Error bars represent standard deviation for three repeated experiments. Statistical
significance was determined by Student’s t-test (***, p < 0.001). (B) Binding of the K38 depolymerase to K38 cells assayed
as described in the material and methods. In brief, recombinant K38 depolymerase was incubated with K38 (sensitive to
the enzyme) or K1 cells (not sensitive to the enzyme) at different time points (0.1, 1, 2, 4, 8 min). Immediately afterward,
samples were centrifuged, and the supernatant was collected and loaded in a 12% SDS-PAGE gel.
2.6. K38 Depolymerase Does Not Synergise with Antibiotics
With the goal of understandin if the capsule disruption could increase susceptibil-
ity to antibiotics, preliminary experiments were performed to analyse whether the K38
depolymerase synergized with antibiotic treatments in biofilms. The three antibiotics
with lowest MIC (Supplemental Figure S2) wer selected for these assays: ciprofloxacin
(MIC = 1 µg/mL), tetracycli e (MIC = 1 µg/ L) and gentamicin (MIC = 2 µg/mL). We
performed co-treatments using antibiotics (5xMIC) in combination with the K38 depoly-
merase (1 µM) against 24 h preformed biofilms in 96-well microtiter plates. Ciprofloxacin,
tetracycline and gentamicin treatments reduced approximately 2, 1 and l logs, compared
with the control group and respectively (Supplemental Figure S3). However, no differences
were observed b tween the use of antibiotics alone and the combined treatments (antibiotic
+ K38 depolymerase) in all tested conditions.
2.7. K38 Depolymerase Increased Susceptibility of K38 Cells to Host Immunity
The capsular degrading activity was also assessed as a potential anti-virulence strategy
against A. pittii. Int restingly, while n -treated K38 cells were fully resistant to serum,
addition of purified recombinant K38 depolymerase to K38 cells led to full susceptibility
to serum (Figure 4). Indeed, in the presence of the depolymerase, the starting 4-log
bacterial inoculum was reduced below detection limit (<10 CFU/mL). As expected, K38
depolymerase had no effect on the resistance of K1 cells to the serum (Figure 4). In all
cases, heat-inactiva d serum combined with the K38 depolymerase had no antibacteri l
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effect (data not shown). These experiments suggested a specific anti-virulence effect of the
depolymerase towards K38 cells in the presence of the host complement system.
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3. Discussion
A first step in the interaction between phages and their bacterial prey involves the
binding of the phage to bacterial surface receptors through receptor binding proteins
usually carried on the phage tail fibers and/or tailspikes. One of the main driving forces in
the evolution of phage genomes is the acquisition of novel receptor binding proteins to
adapt to new ost receptors, in the endless “arms race” between hos defences and phage
counter defences.
Previously, we studied the interaction of Fri1-like ACB complex phages of the
Autographiviridae family. By is lating 12 new phages, we demonstrated that their genomes
were highly similar but encoded specific capsular depolymerase domains to specifically
recognise different host capsules [6]. Later, Fri1-like phages have been reported to inter-
act in total with 17 distinct Acinetobacter capsules (K1–2, K9, K19, K27, K30, K32, K37,
K44–45, K47–48, K87, K89, K91, K93 and K116) [6–10]. Comparing the genome of phage
3043-K38 targeting an untapped K38 capsule with the 45 ACB complex Fri1-like phages de-
posited at GenBank, we confirmed our previous observations that amongst highly similar
genomes, igh variability co ld be found mainly between genes encoding f r the tailspike
(Figure 5A). Their genomes were highly similar, presenting only some synteny breaks in
some hypothetical genes, homing endonuclease, a dNMP kinase, but mostly at the tailspike
genes. If fact, only the ce ter-end of the tailspikes coding for the capsular depolymerase
activity varyied, which can be interpreted as a specific genomic-switch to quickly adapt
phages to new hosts. This impressive genomic similarity, albeit the distinct geographical
and environmental isolations sources, is an obvious statement of the strong selection to
maintain the same genetic structure of all Fri1-like ACB complex phages. Our hypothesis
is that these small viruses (typically 40 Kb), need specialized enzymes (depolymerases) to
reach the inner surface receptors and initiate the infection their otherwise too-small tails
wo ld not reach.
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l activities [6–10] and multiple sequence alignments of their domains, one can
appreciat the vast divers ty of capsul r depolymerases th t in er ct with Acinetoba ter hosts,
which is known to have 125 different capsule types (Figure 5B). Sequences g ouped (clust r) by
similarity are expected to behave similarly, while single sequences (like t e K38 depolym rase)
are unique (Figure 5B). Our an lysis predicts that from the 46 Fri1-l ke ACB complex phages
analysed, 42 are capsule depolymer ses (p ctate_lyase_3, PF12708 do ain ), 2 ar es rase
depolymerase that odify, but not degra e the LPS (esterases with Lipase_GDSL PF00657
domains) and 2 have unique domains (AbKT21phiIII, vB_AbaP_46-62_Aci07). Owing to the
horizontal movement of the tailspikes in Fri1-like ACB complex ph ges genomes observed, it
is likely that these unique domains behave als as depolym rases.
Fri1-like ACB complex phages ncode tailspike with capsular depolymerases that
assemble as trimers. The variation between the theoretical trimeric molecular mass with the
value obtained in gel filtration experiments, agrees with previous observations reporting
that the C-terminal domain functions as a chaperone to help the protein to oligomerise
into trimers, and is then autoproteolytically cleaved [14,15]. The K38 depolymerase study
presented here suggests that the interaction with the capsule may be faster (in the sec-
ond range) when compared with other lipopolysaccharide depolymerases described [16].
Without surprise, the K38 depolymerase harbours a rich β-structure that enables the en-
zyme to endure high thermal stresses, with Tm > 65 ◦C as observed previously with other
A. baumannii, K. pneumoniae and E. coli phage capsular depolymerases [7,17,18].
Potential biotechnological applications of the recombinant depolymerase were also
explored, here. We showed that the recombinant K38 depolymerase degrades capsules,
making cells immune to phage predation. This shows that a combinatorial use of the phage
and its recombinant depolymerase is not advisable for treatment of bacterial infections.
By stripping cells from the capsule coat, K38 depolymerase also increased susceptibility
of bacterial cells to the complement. This agrees with recent findings from similar en-
zymes, the Acinetobacter phage B9 and B3 capsular depolymerases [7,19,20]. However,
K38 depolymerase had no additive or synergistic effect with antibiotics to control biofilms.
To the best of our knowledge, only a single recombinant depolymerase derived from
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Aeromonas punctata was reported to synergize with gentamicin against a K. pneumoniae
biofilm, but its origin and polysaccharide substrate remains to be fully elucidated [21].
While a synergistic depolymerase-antibiotic combination may be depended of the an-
tibiotic mechanism of action, the ability to control biofilms may be ultimately related
with the prevalence of capsule polysaccharides in the extracellular matrix, which will
be strain-dependent.
In summary, by isolating a novel K38 depolymerase we contributed to unpuzzling
Friunavirus-host interactions and highlighted a potential application of these enzymes to
control bacterial infections. Due to the high specificity of these capsular depolymerases
for a given capsule type, epidemiologic studies need to be first conducted in order to
understand the most prevalent ACB complex capsular types circulating in human clinical
isolates. Only then, the anti-virulence therapy based on capsular depolymerases could be
directed and potentially become an alternative to current antimicrobials options, which
are becoming less effective against, drug-resistant infections, such as the ones caused by
ACB species.
4. Material and Methods
4.1. Bacterial Strains and Culture Conditions
A. pittii Ap45 strain was isolated from the drainage liquid collected from a wound of a
patient at the University Hospital of Lausanne (CHUV), Switzerland. Other considered
Acinetobacter strains belonged to the collections of Alexandr Nemec (NIPH and ANC
strains) and the Institute Pasteur (CIP strains), covering a range of 29 different Acinetobacter
K types (K1–3, K7, K9, K11, K14–15, K19, K22, K30, K32–33, K35, K37–38, K40, K43–49, K57,
K73, K83–85) [6,7,19]. Unless otherwise stated, all strains were grown at 37 ◦C in Tryptic
Soy Broth (TSB) or on Tryptic Soy Agar (TSA, 1.2% (wt/vol) agar).
4.2. Bacterial Sequencing and Annotation
A. pittii Ap45 genomic DNA was isolated using the Qiagen DNeasy Blood and Tis-
sue Kit following the manufacturer’s recommendations. Next, bacterial genomic library
preparation was performed by Eurofins Genomics Germany GmbH (Ebersberg, Germany)
with an optimized protocol and standard Illumina adapters. Sequencing was performed
at Eurofins Genomics Germany GmbH (Ebersberg, Germany) with Illumina technology,
NovaSeq 6000 (read mode 2 × 150 bp). Sequencing data were assembled with Geneious
Prime 2020 (Biomatters Ltd., Auckland, New Zealand). Contigs shorter than 500 bp or
with less than eight-fold coverage were removed. Assembled contigs were annotated using
the NCBI Prokaryotic Genome Annotation Pipe-line v4.12 [22]. JSpeciesWS was used to
compute pairwise average nucleotide identity (ANI) values among genomes [23]. Acquired
antibiotic resistance genes were screened using ResFinder 4.0 [24]. Kaptive was used to
identify the Acinetobacter K locus for capsular polysaccharide types [25].
4.3. Phage Isolation and Propagation
Phage 3043-K38 was isolated using the procedures previously described [26]. Briefly,
phages specific for A. pittii Ap45 were amplified from raw sewage water samples (Vidy
wastewater treatment plant, Lausanne, Switzerland) supplemented with Luria Broth
medium and the A. pittii Ap45 strain. After incubation for 24 h at 37 ◦C and 200 rpm,
samples were centrifuged (4000× g, 15 min) and the supernatant filtered (0.45-µm syringe
filters). Plaque-forming units (PFU) were obtained using double-layer assays with serial di-
lutions of the filtered supernatant. Individual PFU were spread into new bacterial lawns at
least three times to ensure selection of a single phage, which was named vB_Api_3043-K38
(3043-K38).
A. pittii phage 3043-K38 was propagated on A. pittii Ap45 strain (K38 capsular type).
Briefly, mid-exponential cultures (OD620nm of 0.3) of A. pittii Ap45 grown in TSB were
infected with the 3043-K38 at a multiplicity of infection (MOI) of 0.01 at 37 ◦C for 4 h. The
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lysate was centrifuged (9000× g, 10 min) and the supernatant was filtered at 0.22 µm and
titrated through double-layer agar assay, following standard procedures [27].
4.4. Electron Microscopy
The phage was imaged in a Jeol JEM 1400 transmission electron microscope (TEM),
precisely as previously described [28].
4.5. Phage Genome Sequencing and Annotation
Genomic DNA was extracted and purified using the phenol-chloroform extraction
method, as described elsewhere [27]. Whole genome library was generated by TruSeq®
Nano DNA Library Prep Kit, sequenced in lllumina MiSeq with a 300 bp paired-end
sequencing read configuration (Stabvida, Portugal) and, de novo, assembled in Geneious
Prime. The assembled genome was annotated with MyRAST [29], BLAST [28], tRNAscan-
SE v2.0 [30] and HHpred [31] with default parameters.
4.6. Tailspike Cloning, Expression and Production
The gene coding for a deletion mutant lacking the N-terminal domain (i.e., amino acid
residue 147–742) of the tailspike encoded by gp46, also referred to as capsular depolymerase,
was amplified with phusion polymerase (Thermo Scientific, Waltham, MA, USA) from the
phage genomic DNA using the following primers: Fw 5′-GGATCCCAGGAAGTACGTTCGGC-
3′ (with BamHI restriction site); Rv 5′-CTCGAGTTAACTCGGTGTAAGTGTAGTACC-3′
(with XhoI restriction site). The gene was cloned in pET28a (Addgene) and transferred into
electrocompetent Escherichia coli BL21 cells for recombinant expression. Protein synthesis
was induced in mid-exponential cultures (OD620nm of 0.5) with 1 µM of isopropyl-β-D-
thiogalactoside (IPTG) at 21 ◦C under agitation for 16 h. Next, cells were pelleted (9000× g,
30 min), resuspended in lysis buffer (50 mM Tris-HCl pH 8.0, 300 mM NaCl), and me-
chanically disrupted by three freeze/thaw cycles and sonication (Cole-Parmer, Ultra-sonic
Processors) for 8–10 cycles (30 s pulse, 30 s pause, 40%). Capsular depolymerase was puri-
fied through immobilized metal affinity chromatography (IMAC) on nickel columns using
an imidazole gradient (25 to 250 mM). Eluted samples were separated on 12% polyacry-
lamide gel electrophoresis (SDS-PAGE) and dialyzed in 10-mM phosphate buffered saline
(PBS, pH 7.5). Next, protein samples were further purified by size exclusion chromatogra-
phy performed on an Azura FPLC system (KNAUER) at 4 ◦C. Sample was applied to a
Superose 6 10/300 GL column (GE Healthcare, Chicago, IL, USA) in 10-mM PBS (pH 7.5).
Elution was conducted at a flow rate of 0.75 mL/min and the protein was detected at A280.
Molecular weight was estimated using protein standards (Merck). The purified protein was
quantified by the Pierce™ BCA Protein Assay Kit (Thermo Scientific, Waltham, MA, USA).
4.7. Phage Host Range and Depolymerase Activity Spectrum
A panel of 29 different Acinetobacter K types (K1–3, K7, K9, K11, K14–15, K19, K22, K30,
K32–33, K35, K37–38, K40, K43–49, K57, K73, K83–85) [6,7,19] was used to check 3043-K38
host range and the activity spectrum of the recombinant capsular depolymerase. After over-
laying overnight cultures in Tryptic Soy Agar (TSA) plates, 5-µL drops of phage 3043-K38
(108 PFU/mL) or of the recombinant capsular depolymerase (1 µM) were spotted and
plates incubated at 37 ◦C overnight. Susceptibility to phage or depolymerase was defined
as appearance of clear or opaque lysis zones (halos) at the deposition sites, respectively.
4.8. Circular Dichroism Spectroscopy
The secondary structure of the capsular depolymerase (10 µM) was analysed by
circular dichroism (Jasco J-1500 spectrometer) measuring the ellipticity spectrum (average
of three accumulations with baseline correction) from 190 to 250 nm, with 1 nm steps,
scanning speed of 20 nm/min, high sensitivity and 16-s response time. Additionally,
thermal unfolding was analysed by monitoring the ellipticity (at 217 nm), heating the
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protein (1 ◦C/min) from 25 ◦C to 100 ◦C. Melting curves were obtained after fitting the
data in a Boltzmann sigmoidal function.
4.9. Binding Assay
This assay was performed as previously described, with minor modifications [16].
Overnight cultures of K38 strain (3043-K38 host) and K1 strain (3043-K38 non-host) were
adjusted to an optical density (OD600nm) of 1.0. A small fraction of the cultures (6 mL)
was pelleted (5000× g, 5 min at 4 ◦C) and resuspended in 200 µL of 10-mM PBS (pH 7.5)
containing the tailspike (2 µM final concentration). The mixture was incubated at 37 ◦C
with agitation. At different time points, the cells were pelleted (20,000× g, 30 s at room
temperature) and the supernatant (30 µL) was recovered and loaded into 12% SDS-PAGE
gel stained with Coomassie Blue.
4.10. Adsorption Assay
Pull-down assays were performed as previously described, with minor modifica-
tions [19]. Overnight cultures of K38 strain (3043-K38 host) and K1 strain (3043-K38
non-host) were diluted to 108 CFU/mL and incubated with PBS or the capsular depoly-
merase (1 µM final concentration) for 2 h at room temperature. Next, cells were pelleted
(8000× g, 2 min), washed twice in PBS and incubated with the phage 3043-K38 (MOI
of 0.001) at 37 ◦C for 5 min with agitation. Phage was tittered before (total phage titre)
and after centrifugation (non-adsorbed phage titre) in K38 strain. The phage adsorption
was obtained by subtracting both and expressing the results in percentage. Averages and
standard deviations of three repeated experiments are given. Significance was determined
by Student’s t-test (***, p < 0.001).
4.11. MIC Determination and Antibiofilm Assays
The minimum inhibitory concentration (MIC) values of eight different antibiotics
(ciprofloxacin, erythromycin, tetracycline, spectinomycin, kanamycin, ampicillin, cef-
tazidime and gentamicin) were determined for A. pittii Ap45 strain in TSB using the
broth microdilution method according to a previously described protocol [32]. These
assays were performed in triplicate.
Three antibiotics (ciprofloxacin, tetracycline and gentamicin) were selected to perform
antibiofilm assays in combination with the K38 depolymerase. For this, overnight cultures
of A. pittii Ap45 were diluted 1:100 in TSB and 200 µL of the bacterial suspension were
added to the wells of 96-well polystyrene microtiter plates (Orange Scientific). The plates
were then incubated in an orbital incubator for 24 h at 37 ◦C and 120 rpm to allow biofilm
growth. After biofilm formation, the media and planktonic bacteria were removed, the
wells were washed with fresh TSB and incubated with (1) antibiotics (5xMIC), (2) capsular
depolymerase (1 µM), (3) antibiotic (5xMIC) + depolymerase (1 µM) or (4) PBS buffer (con-
trol). The plates were incubated at 37 ◦C with agitation (120 rpm) and the colony forming
units (CFU)/mL were counted at 6 h and 24 h. Three independent assays were performed.
4.12. Human Serum Assay
The anti-virulence properties of the capsular depolymerase were tested in serum as
previously described [7]. In brief, overnight cultures of K38 strain (3043-K38 host) and K1
strain (3043-K38 non-host) diluted in TSB to 104 CFU/mL were added to human serum
collected from healthy volunteers at a 1:3 volume ratio. Next, infected serum was incubated
either with PBS or the capsular depolymerase (1 µM final concentration) for 1 h at 37 ◦C.
Similar samples supplemented with decomplemented serum (at 56 ◦C for 30 min) were
used as controls. Survival bacterial cells were determined by CFUs counts. Averages and
standard deviations of three repeated experiments are given. Significance was determined
by Student’s t-test (***, p < 0.001).
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4.13. Nucleotide Sequence Accession Numbers
A. pittii phage vB_Api_3043-K38 genome was deposited in GenBank under accession
number MZ593174. The sequencing reads and assembled contigs of the A. pittii Ap45 strain
are provided under the BioProject accession number PRJNA750264.
Supplementary Materials: The following are available online at https://www.mdpi.com/article/
10.3390/antibiotics10111304/s1. Figure S1. K38 depolymerase activity. Figure S2. MIC values.
Figure S3. Biofilm assays.
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